Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 3
2014 7
2015 7
2016 8
2017 12
2018 8
2019 15
2020 19
2021 20
2022 21
2023 13
2024 17
2025 17

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

150 results

Results by year

Filters applied: . Clear all
Page 1
Accuracy of Predicting Residual Disease and Disease Progression During Active Surveillance for Esophageal Cancer.
Gangaram Panday SSG, van Klaveren D, Lagarde SM, Lingsma HF, Mostert B, Coene PLO, Dekker JWT, Hartgrink HH, Heisterkamp J, Hutteman M, Kouwenhoven EA, Nieuwenhuijzen GAP, Pierie JP, van Sandick JW, Sosef MN, van der Zaag ES, van Lanschot JJB, Wijnhoven BPL; SANO Study Group. Gangaram Panday SSG, et al. Among authors: van klaveren d. Ann Surg Oncol. 2025 Oct 23. doi: 10.1245/s10434-025-18531-y. Online ahead of print. Ann Surg Oncol. 2025. PMID: 41128955
Early-life prediction of school-age asthma among recurrent Wheezers in preschoolers: The WHEEP study.
Karramass T, Mancino E, Balemans W, Brouwer M, De Groot E, Landstra AM, Merkus PJFM, Niers LEM, Vaessen-Verberne A, van Klaveren D, Vermeulen H, Verwaal M, Pijnenburg M, Duijts L. Karramass T, et al. Among authors: van klaveren d. Pediatr Allergy Immunol. 2025 Oct;36(10):e70219. doi: 10.1111/pai.70219. Pediatr Allergy Immunol. 2025. PMID: 41078137 Free PMC article.
Development and Validation of a Prognostic Model for Persistent Hypoparathyroidism After Total or Completion Thyroidectomy.
van Dijk SPJ, Maas CCHM, Alshangi A, van Driel MHE, Feitsma EA, van Kinschot CMJ, Lončar I, van Noord C, Koppert LB, Kruijff S, van Klaveren D, Verhoef C, Peeters RP, van Ginhoven TM; Hypoparathyroidism Study Group of the Thyroid Network. van Dijk SPJ, et al. Among authors: van klaveren d. Clin Otolaryngol. 2025 Oct 2. doi: 10.1111/coa.70039. Online ahead of print. Clin Otolaryngol. 2025. PMID: 41036820
[Financial toxicity in cancer patients].
Klok JM, Van Klaveren D, Aerts JGJV. Klok JM, et al. Among authors: van klaveren d. Ned Tijdschr Geneeskd. 2025 Jul 10;169:D8490. Ned Tijdschr Geneeskd. 2025. PMID: 40673356 Dutch.
External validation of a model to predict recurrence-free and melanoma-specific survival for patients with melanoma after sentinel node biopsy.
Stassen RC, Maas CCHM, Leong SP, Kashani-Sabet M, White RL, Pockaj BA, Zager JS, Schneebaum S, Vetto JT, Avisar E, Harrison Howard J, O'Donoghue C, Kosiorek H, van Akkooi ACJ, Verhoef C, van Klaveren D, Grünhagen DJ, Olofsson Bagge R. Stassen RC, et al. Among authors: van klaveren d. Br J Surg. 2025 Mar 28;112(4):znaf037. doi: 10.1093/bjs/znaf037. Br J Surg. 2025. PMID: 40243383 Free PMC article.
Neoadjuvant chemoradiotherapy followed by active surveillance versus standard surgery for oesophageal cancer (SANO trial): a multicentre, stepped-wedge, cluster-randomised, non-inferiority, phase 3 trial.
van der Wilk BJ, Eyck BM, Wijnhoven BPL, Lagarde SM, Rosman C, Noordman BJ, Valkema MJ, Bisseling TM, Coene PLO, van Det MJ, Dekker JWT, van Dieren JM, Doukas M, van Esser S, Fiets WE, Hartgrink HH, Heisterkamp J, Holster IL, Klarenbeek B, van Klaveren D, Kouw E, Kouwenhoven EA, Luyer MD, Mostert B, Nieuwenhuijzen GAP, Oostenbrug LE, Pierie JP, van Sandick JW, Sosef MN, Spaander MCW, Valkema R, van der Zaag ES, Steyerberg EW, van Lanschot JJB; SANO Study Group. van der Wilk BJ, et al. Among authors: van klaveren d. Lancet Oncol. 2025 Apr;26(4):425-436. doi: 10.1016/S1470-2045(25)00027-0. Epub 2025 Mar 17. Lancet Oncol. 2025. PMID: 40112851 Clinical Trial.
150 results